Skip to main content

Table 1 Baseline Demographic information of patient with CSM

From: Clinical impact and imaging results after a modified procedure of ACDF: a prospective case-controlled study based on ninety cases with two-year follow-up

Variable Spread group (n = 48) None-spread group (n = 42) P Value
Age, mean ± SD, y 59.54 ± 17.65 60.07 ± 15.21 .880
Female, No. (%) 28 (58.33) 25 (59.52) .909
Hypertension, No. (%) 29 (60.42) 27 (64.29) .706
Atrial fibrillation, No. (%) 18 (37.50) 17 (40.48) .773
Smokers, No. (%) 21 (43.75) 19 (45.24) .887
Diabetes, No. (%) 12 (25.00) 9 (21.43) .689
Operated level, No. 48 42  
 C3/C4, No. (%) 6 5 .868
 C4/C5, No. (%) 14 11
 C5/C6, No. (%) 23 24
 C6/C7, No. (%) 3 1
 C7/T1, No. (%) 2 1
Average follow-up time(m) 28.37 ± 3.60 29.82 ± 3.25 .367
Re-operation rates 8.3% (4/48) 4.8% (2/42) 0.799